Abide Therapeutics Appoints CMO
This article was originally published in Scrip
Abide Therapeutics has appointed Chan Beals chief medical officer (CMO). Most recently, Beals was entrepreneur in residence with Merck Research Laboratories Ventures and prior to this, he was vice president and head of clinical pharmacology and experimental therapeutics at Merck & Co.
Register for our free email digests: